Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384132020> ?p ?o ?g. }
- W4384132020 endingPage "1936" @default.
- W4384132020 startingPage "1936" @default.
- W4384132020 abstract "Substrate reduction therapy (SRT) has been proposed as a new gene therapy for Fabry disease (FD) to prevent the formation of globotriaosylceramide (Gb3). Nanomedicines containing different siRNA targeted to Gb3 synthase (Gb3S) were designed. Formulation factors, such as the composition, solid lipid nanoparticles (SLNs) preparation method and the incorporation of different ligands, such as gold nanoparticles (GNs), protamine (P) and polysaccharides, were evaluated. The new siRNA–golden LNPs were efficiently internalized in an FD cell model (IMFE-1), with GNs detected in the cytoplasm and in the nucleus. Silencing efficacy (measured by RT-qPCR) depended on the final composition and method of preparation, with silencing rates up to 90% (expressed as the reduction in Gb3S-mRNA). GNs conferred a higher system efficacy and stability without compromising cell viability and hemocompatibility. Immunocytochemistry assays confirmed Gb3S silencing for at least 15 days with the most effective formulations. Overall, these results highlight the potential of the new siRNA–golden LNP system as a promising nanomedicine to address FD by specific SRT." @default.
- W4384132020 created "2023-07-14" @default.
- W4384132020 creator A5011124617 @default.
- W4384132020 creator A5024141938 @default.
- W4384132020 creator A5030935357 @default.
- W4384132020 creator A5037711682 @default.
- W4384132020 creator A5059930778 @default.
- W4384132020 creator A5074302488 @default.
- W4384132020 date "2023-07-12" @default.
- W4384132020 modified "2023-10-17" @default.
- W4384132020 title "Novel Golden Lipid Nanoparticles with Small Interference Ribonucleic Acid for Substrate Reduction Therapy in Fabry Disease" @default.
- W4384132020 cites W1563674070 @default.
- W4384132020 cites W1837847035 @default.
- W4384132020 cites W1940965633 @default.
- W4384132020 cites W1967337419 @default.
- W4384132020 cites W2013670506 @default.
- W4384132020 cites W2025582103 @default.
- W4384132020 cites W2037236265 @default.
- W4384132020 cites W2038720758 @default.
- W4384132020 cites W2043048568 @default.
- W4384132020 cites W2043504487 @default.
- W4384132020 cites W2045029341 @default.
- W4384132020 cites W2055553682 @default.
- W4384132020 cites W2066148691 @default.
- W4384132020 cites W2087812848 @default.
- W4384132020 cites W2123814020 @default.
- W4384132020 cites W2141918017 @default.
- W4384132020 cites W2157979200 @default.
- W4384132020 cites W2182835963 @default.
- W4384132020 cites W2292743908 @default.
- W4384132020 cites W2471932932 @default.
- W4384132020 cites W2479157102 @default.
- W4384132020 cites W2500404244 @default.
- W4384132020 cites W2537272949 @default.
- W4384132020 cites W2566128997 @default.
- W4384132020 cites W2573607409 @default.
- W4384132020 cites W2584307810 @default.
- W4384132020 cites W2601708340 @default.
- W4384132020 cites W2730674580 @default.
- W4384132020 cites W2791748613 @default.
- W4384132020 cites W2888421608 @default.
- W4384132020 cites W2906680312 @default.
- W4384132020 cites W2917201626 @default.
- W4384132020 cites W2955024369 @default.
- W4384132020 cites W2968060972 @default.
- W4384132020 cites W2972821158 @default.
- W4384132020 cites W2993208076 @default.
- W4384132020 cites W2996345353 @default.
- W4384132020 cites W3047437072 @default.
- W4384132020 cites W3048467449 @default.
- W4384132020 cites W3088340485 @default.
- W4384132020 cites W3093405310 @default.
- W4384132020 cites W3095652295 @default.
- W4384132020 cites W3113363715 @default.
- W4384132020 cites W3113542701 @default.
- W4384132020 cites W3118949809 @default.
- W4384132020 cites W3133320304 @default.
- W4384132020 cites W3156651800 @default.
- W4384132020 cites W3159333219 @default.
- W4384132020 cites W3160431638 @default.
- W4384132020 cites W3164967630 @default.
- W4384132020 cites W3173649809 @default.
- W4384132020 cites W3193875799 @default.
- W4384132020 cites W3200667730 @default.
- W4384132020 cites W3201277528 @default.
- W4384132020 cites W4200081413 @default.
- W4384132020 cites W4220674093 @default.
- W4384132020 cites W4250144914 @default.
- W4384132020 cites W4286219820 @default.
- W4384132020 cites W4292702578 @default.
- W4384132020 cites W4307552170 @default.
- W4384132020 cites W4308122138 @default.
- W4384132020 cites W4308558941 @default.
- W4384132020 cites W4309495265 @default.
- W4384132020 cites W4313397127 @default.
- W4384132020 cites W4318934403 @default.
- W4384132020 cites W4321374254 @default.
- W4384132020 cites W4323660325 @default.
- W4384132020 doi "https://doi.org/10.3390/pharmaceutics15071936" @default.
- W4384132020 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37514122" @default.
- W4384132020 hasPublicationYear "2023" @default.
- W4384132020 type Work @default.
- W4384132020 citedByCount "0" @default.
- W4384132020 crossrefType "journal-article" @default.
- W4384132020 hasAuthorship W4384132020A5011124617 @default.
- W4384132020 hasAuthorship W4384132020A5024141938 @default.
- W4384132020 hasAuthorship W4384132020A5030935357 @default.
- W4384132020 hasAuthorship W4384132020A5037711682 @default.
- W4384132020 hasAuthorship W4384132020A5059930778 @default.
- W4384132020 hasAuthorship W4384132020A5074302488 @default.
- W4384132020 hasBestOaLocation W43841320201 @default.
- W4384132020 hasConcept C104317684 @default.
- W4384132020 hasConcept C119056186 @default.
- W4384132020 hasConcept C142724271 @default.
- W4384132020 hasConcept C15083742 @default.
- W4384132020 hasConcept C153911025 @default.
- W4384132020 hasConcept C155672457 @default.
- W4384132020 hasConcept C166703698 @default.